Skip to content

Ragosa Mark

Reporting owner on Forms 3, 4 and 5, CIK 1835458.

Ragosa Mark reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-03.

Issuers

IssuerRoles in the latest filingFilingsLast filed
KNSA · Kiniksa Pharmaceuticals International, plcCIK 1730430officer (CHIEF FINANCIAL OFFICER)12026-11-03

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02M exercised+9,636$10.7630,490Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02M exercised+5,388$11.135,878Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02M exercised+12,123$11.9748,001Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02M exercised+9,636$17.7657,637Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02S sold-14,027$91.443,610Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02S sold-10,502$92.0333,108Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02S sold-12,034$93.1321,074Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02S sold-220$94.0120,854Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-02M exercised-9,636$04,380Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-02M exercised-5,388$00Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-02M exercised-12,123$00Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-02M exercised-9,636$08,760Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001835458-26-000014 Kiniksa Pharmaceuticals International, plc2026-11-03